Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04089020 · ClinicalTrials.gov registry record · NA

Walking to School Supports

A NA study, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT04089020: Completed NA study, sponsored by Children's Mercy Hospital Kansas City.

NCT04089020 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04089020, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

This pilot study will test the feasibility and acceptability of an enhanced individual-level intervention delivered to 4th-6th graders to increase rates of walking to/from school. Up to 8 youth who do not already walk to school will be enrolled into the intervention. The theoretically-based intervention content will be delivered over 6 weeks through family-based telephone coaching sessions, ongoing short message service (SMS) text messaging, and activities and content on the study website.

Primary Outcome

Acceptability and preferences related to intervention content will be measured using a questionnaire developed for this study ("satisfaction questionnaire"). Families (both parent and child responding together) will respond to 5 items asking about satisfaction with the intervention components. Items are rated on a 10-pt scale (minimum:1- maximum:10), with higher values indicating greater satisfaction. They will respond to two additional open-ended questions asking which aspects of the interventi

Interventions

  • BEHAVIORAL Support for walking to school

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2019-09-25
Est. Completion 2020-01-31
Phase NA

What the finished NCT04089020 record still lists

NCT04089020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Support for walking to school is the first listed.

NCT04089020 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04089020 about?

NCT04089020 is a clinical study titled "Walking to School Supports". This pilot study will test the feasibility and acceptability of an enhanced individual-level intervention delivered to 4th-6th graders to increase rates of walking to/from school. Up to 8 youth who do not already walk to school will be enrolled into the intervention. The theoretically-based interven...

What is the current status of trial NCT04089020?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-09-25. Estimated completion is 2020-01-31.

What interventions are being tested in trial NCT04089020?

The interventions under investigation include: Support for walking to school (BEHAVIORAL).

Who is sponsoring clinical trial NCT04089020?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04089020's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04089020, the US trial registry maintained by the National Library of Medicine. NCT04089020 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.